International Patent: ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO A2AP AND MEDICAL USE THEREOF

GENEVA, Oct. 5 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. filed a patent application (CN2026/086455) for “ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO A2AP AND MEDICAL USE THEREOF”. With publication no. WO/2026/201111, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/38

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....